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The genome of ovine adenovirus OAV287 has an arrangement which is unique among known adenoviruses. To facilitate
further experimentation on the structure and function of this genome, plasmids containing a complete clone of the genome
were constructed. The cloned viral genome was released from plasmids by restriction enzyme digestion as an intact linear
molecule with authentic 5* termini. Transfection of the linear DNA into cells which supported replication produced infectious
virus. Mutation of a unique SalI site at the right-hand end of the genome disrupted reading frames of unknown function
without affecting virus rescue, identifying this region as nonessential for replication in vitro. A 20-bp oligonucleotide was
also inserted into the short intergenic region between the pVIII and the fiber sequences, identifying a second site for gene
insertion. These studies will facilitate the development of OAV as a gene transfer vector. q 1996 Academic Press, Inc.
Human adenoviruses (Ad) have been studied for many quence of OAV287 was recently completed (22–24). This
years. They are well characterized and have provided revealed that the OAV E3 sequences were not present
important insights into gene regulation and virus replica- between the pVIII and the fiber genes. However, two
tion (reviewed in 10). This has led to their adaptation as other groups of open reading frames which showed little
vectors for vaccine and gene therapy applications (1, 7). or no detectable homology to other Ad genomes were
In contrast, adenoviruses from animal and avian species located at the right-hand end of the genome on the right-
are less well studied. Partial characterization of some to-left strand (23). To begin to investigate the structure
viruses has been reported and some structural protein and function of these regions and to facilitate further
homologues have been described (3–5, 12, 16, 19, 21). development of OAV as a vector we constructed a plas-
Avian Ads perhaps represent the most distinct virus mid carrying a full length, infectious clone of the OAV
group studied to date but, in general, the genome ar- genome. Mutagenesis was used to identify two potential
rangement in the animal Ads is similar to that of the sites for the insertion of gene expression cassettes.
human Ads. Homologies can be detected between most Procedures for the growth of OAV in CSL503 cells,
animal Ad proteins and their human Ad counterparts. virus purification, and isolation of the linear viral DNA
Similarly, the group of reading frames comprising the E3 were described previously (2, 18). OAV genomic DNA
region is always located between the pVIII and the fiber was cloned as BamHI fragments (2) which occur from
genes although its size and complexity varies in animal left to right in the genome in the order D, B, C, E, F, and
Ads compared with human Ads. These sequences are A. OAV genomic fragments were modified using phos-
of interest because in human Ads the E3 region is nones- phorylated synthetic oligonucleotides of the desired se-
sential for replication in vitro (14) and can therefore be quence and mutagenesis kits (Muta-Gene Phagemid,
replaced by foreign DNA (11, 17). The identification of Bio-Rad Labs; Altered Sites II, Promega Corp., Madison,
similar nonessential sequences in ovine adenovirus WI). The terminal BamHI A and D fragments (cloned in
(OAV) might therefore assist the development of this virus the BamHI/HincII sites of Bluescribe M13/ (Stratagene,
as a vector. La Jolla, CA) were each modified at the 5* terminus of
The determination of the complete nucleotide se- the inverted terminal repeat (ITR) to restore two nucleo-
tides (CT) lost during cloning (2) and to create a KpnI
site, producing plasmids pAK and pDK. The genomic
1 Present address: National Institute for Immunology, JNU Campus, BamHI B fragment was modified by mutagenesis (GCA-110 067, New Dehli, India.
TGC to GCATCC) to remove the SphI site at position2 To whom correspondence and reprint requests should be ad-
dressed. 8287 producing pBM. This modified BamHI B fragment
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FIG. 1. Construction of plasmids containing a full length clone of the OAV genome. Plasmid pOAV287Cm was constructed from partial genomic
clones and pOAV100 was derived from it as described in the text. Open sequences in pOAV287Cm are from pACYC184. In pOAV100 they are
derived from modified Bluescribe M130.
was linked to the terminal D fragment in plasmid pDBM. site. After digestion with KpnI this plasmid was ligated
with KpnI-cut pOAV287Cm. Plasmids which were AmpR/The SphI A fragment (13 kb) was cloned into pSELECT
(Promega) to form pSESPH. This fragment had a SmaI CmR were selected and grown. One of these was cut
with SalI to release the pACYC184 sequences, religated,site in common with pDBM near its left-hand end. The
KpnI/SmaI fragment from pDBM was subcloned into and transformed. The resulting plasmid, pOAV100, car-
ried the AmpR gene and an origin of replication in thepSESPH to produce pSELLH which now contained the
left-hand 21.5 kb of the OAV genome. Plasmid pAK KpnI site between the genomic ITRs (Fig. 1). This plasmid
replicated stably in E. coli strain JM109. Digestion ofcontained the right-hand BamHI A fragment of 8.6 kb
which overlapped the SphI A fragment in pSELLH. pAK pOAV100 with KpnI released potentially infectious, linear
viral DNA which had the correct 5* nucleotides.was cut at a unique SalI site and ligated with SalI-cut
pACYC184 (20) (4.24 kb) to form pACm. pACm was cut Twenty-four hours prior to transfection, sheep fetal
lung CSL503 cells (18) were seeded at a density of 3.5with SphI and KpnI to produce the right-hand genomic
fragment incorporating the pACYC184 sequences. This 1 105 per 55-mm dish with EMEM (5 ml) (Multicel, Trace
Scientific, Clayton, Victoria) containing 10% FCS. Linearwas ligated with the left-hand KpnI/SphI fragment of
21.5 kb prepared from pSELLH to produce the final DNA purified from OAV by proteinase K digestion (2) or
cloned genomic DNA released from pOAV100 or relatedplasmid pOAV287Cm (Fig. 1). This plasmid replicated
stably in Escherichia coli strain JM109. Yields were im- plasmids by KpnI digestion (3–6 mg/dish) was trans-
fected into cells using Lipofectamine (10 ml) (Life Tech-proved by the growing cultures in the presence of 200
mg/ml ampicillin. nologies, Inc., Gaithersburg, MD) using procedures rec-
ommended by the supplier, except that serum-freeThe presence of pACYC184 sequences in the SalI site
of pOAV287Cm disrupted two open reading frames (23) EMEM used during the transfection also contained fresh
glutamine (2 mM), HEPES (10 mM), penicillin (50 units/of unknown function. Therefore pOAV287Cm was modi-
fied further. Plasmid Bluescribe M130 (Stratagene) was ml), and streptomycin (50 mg/ml). Following transfection
the cells were incubated for 5 hr in EMEM lacking FCS.cut with HindIII and end filled, then cut with SmaI, blunt-
end ligated, and transformed. The resulting plasmid The medium was then changed and cells were incubated
in EMEM plus 10% FCS until a cytopathic effect (CPE)lacked SalI and SphI sites, but retained a unique KpnI
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was visible (7–20 days). When CPE was complete, virus
was harvested and a stock was grown by reinfecting
fresh CSL503 cells (8). DNA was extracted (8) and char-
acterized by restriction enzyme digestion to confirm that
the recombinant had the expected genome structure.
To carry out structure/function studies on the OAV ge-
nome and to adapt it as a vector it was necessary to be
able to introduce viral DNA into cells and recover it as
the corresponding infectious virus. Initially, naked linear
DNA was prepared from purified virus as described (2)
FIG. 3. Organization of the OAV genome according to (23) showingand transfected into CSL503 cells. Wild-type virus was
the location of site I and II modifications and insertions.recovered from the transfected cells, confirming that the
viral genomic DNA was infectious. Thus, our strategy to
modify the OAV genome was to construct a plasmid from in the terminal protein gene which removed the SphI site
at base 8287. pOAV100 was digested with KpnI and thewhich a linear copy of the genome with the authentic 5*
nucleotides could be derived, and then to show that it linear DNA was transfected into CSL503 cells. A virus
was rescued and its genomic DNA subjected to restric-was infectious. This was achieved in two steps. First,
pOAV287Cm was constructed (Fig. 1). In this plasmid a tion analysis. This confirmed that its overall structure was
correct. Portions of this genome, which contained theprokaryotic origin of replication and a gene encoding
CmR (contained in pACYC184) were cloned into the SphI site mutation, and wild-type genomic DNA were
then amplified by PCR and digested with SphI. As theunique SalI site of the genome and the ITRs were linked
wild-type, but not the OAV100, DNA fragment was cut byback to back by a GTAC linker which, together with the
SphI (Fig. 2A, lanes 3 vs 5), this showed that a modified3* and 5* nucleotides of the genome, created a unique
genome had been rescued (as distinct from contamina-KpnI site. Nucleotide sequencing of the two ITR-con-
tion by a wild-type virus) and confirmed that the assem-taining fragments showed that these sequences re-
bled genomic clone was infectious.mained intact after replication of the plasmid in E. coli,
To determine whether there were any nonessentialeven though ITR sequences linked directly in other Ad
regions in the genome (such as the E3 region in otherplasmids initially underwent rearrangements in prokary-
Ads) pOAV100 was mutated and virus rescue was at-otes (6). As it was anticipated that a substitution in the
tempted. Sequences in the two groups of reading framesSalI site would disrupt the reading frame(s) in the ge-
near the right-hand end of the genome (Fig. 3) werenome, pACYC184 sequences were later excised and a
targeted. The BamHI A fragment of the genome was sub-modified Bluescribe plasmid (AmpR) was cloned into the
cloned into a plasmid so that sequences between theKpnI site, forming pOAV100 (Fig. 1). This plasmid differed
NdeI sites at nucleotides 24,048 and 24,887 could befrom the wild-type genome by one silent point mutation
excised. Deletion of this 739-bp fragment disrupted three
potential reading frames including a 30.8-kDa ORF which
showed homology to the E4 34-kDa protein of other Ads
(23). Subsequently, the modified SphI/SalI fragment lack-
ing these sequences was subcloned into SphI/SalI-cut
pOAV100. In addition, the unique SalI site at the right-
hand end of the genome (Fig. 3) was destroyed by end-
filling and ligation, disrupting open reading frames of 185
(22.3 kDa, Ref. 23) and 62 residues. Genomic plasmids
lacking the NdeI fragment or the SalI site were
transfected to determine whether viruses could be recov-
ered. Despite several attempts, no virus lacking the NdeI
fragment was rescued, suggesting those sequences
within the proposed E4 region (23) were not dispensable
for replication in vitro. However, a virus lacking the SalI
site was rescued. Digestion with BamHI and SalI pro-FIG. 2. Analysis of rescued viral genomes. Portions of the OAV287
and modified OAV100 and OAV200 genomes were amplified by PCR duced fragments of 8.7, 6.7, 5.2, 4.3, 3.5, and 1.1 kb, which
using primer pairs flanking (A) the SphI site or (B) the site I insertion reflected the expected genome structure. Thus, at least
point between the pVIII and the fiber genes. A portion of each PCR one significant open reading frame at the right-hand end
product was left undigested (lanes A2, A4, B2, and B7) or was digested
of the genome was dispensable for replication in vitrowith the appropriate restriction enzyme as indicated (lanes A3, A5, B3–
and could be used for insertion of foreign DNA.5, and B8– 10). U, undigested; A, ApaI; E, EcoRV; N, NotI. Lanes A1,
B1, and B6 contain marker DNA fragments. As the intergenic region between the OAV pVIII and
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fiber genes was 197 bp and the location of RNA pro- hand end of the genome. A significant reading frame
which is disrupted by modification of this site is clearlycessing signals was known (22), we investigated
nonessential for replication in vitro. However, neither thiswhether a small insertion could be introduced into this
reading frame nor others nearby show detectable homol-region. A 20-bp sequence incorporating sites for the re-
ogy to any E3 sequences in other Ads (23). Their functionstriction enzymes ApaI, EcoRV, and NotI was inserted 5*
in replication is therefore unclear.to base 26,645 by mutagenesis. The appropriate virus
In conclusion, the work described here lays the foun-was rescued following transfection, as shown by PCR
dation for the development of this virus as a vector andamplification and digestion of the relevant portion of the
for further structure and function studies on this unusualgenome (Fig. 2B, lanes 3–5). Thus, a second site for
viral genome.gene insertion was identified.
The unusual genome structure of OAV 287 (23) raised
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